DR. BONNIE J BROOKS M.D.
Prescription History 1912973264
Ophthalmology in Brunswick, GA


Quality Rating: 76.1 out of 100 score

NPI Status: Active since February 27, 2006

Contact Information

3303A GLYNN AVE
BRUNSWICK, GA
ZIP 31520
Phone: (912) 466-9500
Fax: (912) 466-9922

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. BONNIE J BROOKS M.D., an active Ophthalmology specialist practicing in Brunswick, GA. Our medical registry currently tracks 34 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 2,188 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 455 claims alone.


Acyclovir

Generic Formulation: AcyclovirSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 19
30-Day Fills 57.0
Days Supply 1,710
GA State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills36.7
Peer Average Days Supply969
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $763.71 across this reporting matrix range.

Provider Avg Cost Per Claim

$40.20

State Avg Cost Per Claim

$23.77

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes.

Therapeutic Applications

Acyclovir is used to treat infections caused by certain types of viruses. It treats cold sores around the mouth (caused by herpes simplex), shingles (caused by herpes zoster), and chickenpox. This medication is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, acyclovir is used to help reduce the number of future episodes. Acyclovir is an antiviral drug. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Acyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. In addition, in people with a weakened immune system, acyclovir can decrease the risk of the virus spreading to other parts of the body and causing serious infections.

Alphagan P

Generic Formulation: Brimonidine TartrateSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 15
30-Day Fills 28.7
Days Supply 855
GA State Average Benchmarks
Peer Average Claims40.0
Peer Average 30-Day Fills66.8
Peer Average Days Supply1,906
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 62.5% less volume than the regional standard for practitioners inside GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $6,069.88 across this reporting matrix range.

Provider Avg Cost Per Claim

$404.66

State Avg Cost Per Claim

$384.16

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

Therapeutic Applications

This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details.

Brimonidine Tartrate

Generic Formulation: Brimonidine TartrateSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 192
30-Day Fills 447.1
Days Supply 13,303
GA State Average Benchmarks
Peer Average Claims76.0
Peer Average 30-Day Fills144.9
Peer Average Days Supply4,212
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 152.6% higher than the standard regional baseline profile for GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $4,946.26 across this reporting matrix range.

Provider Avg Cost Per Claim

$25.76

State Avg Cost Per Claim

$41.97

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

Therapeutic Applications

This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details.

Brimonidine Tartrate-Timolol

Generic Formulation: Brimonidine Tartrate/TimololSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 15
30-Day Fills 28.5
Days Supply 820
GA State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills42.3
Peer Average Days Supply1,203
Conservative Utilization

This provider writes prescriptions for this formulation 42.3% less frequently than the standard regional baseline metric for practitioners inside GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $5,265.82 across this reporting matrix range.

Provider Avg Cost Per Claim

$351.05

State Avg Cost Per Claim

$298.13

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients.

Therapeutic Applications

This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details.

Brinzolamide

Generic Formulation: BrinzolamideSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 17
30-Day Fills 40.9
Days Supply 1,225
GA State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills48.8
Peer Average Days Supply1,452
Conservative Utilization

This provider writes prescriptions for this formulation 34.6% less frequently than the standard regional baseline metric for practitioners inside GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $8,817.33 across this reporting matrix range.

Provider Avg Cost Per Claim

$518.67

State Avg Cost Per Claim

$337.24

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Brinzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors.

Bromfenac Sodium

Generic Formulation: Bromfenac SodiumSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 16
30-Day Fills 16.0
Days Supply 192
GA State Average Benchmarks
Peer Average Claims45.0
Peer Average 30-Day Fills47.6
Peer Average Days Supply1,139
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 64.4% less volume than the regional standard for practitioners inside GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,312.52 across this reporting matrix range.

Provider Avg Cost Per Claim

$144.53

State Avg Cost Per Claim

$147.47

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat swelling (inflammation) and pain in the eye after a certain type of eye surgery (cataract surgery). Bromfenac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking the effects of certain natural substances (prostaglandins) that cause pain and inflammation.

Combigan

Generic Formulation: Brimonidine Tartrate/TimololSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 26
30-Day Fills 56.5
Days Supply 1,666
GA State Average Benchmarks
Peer Average Claims54.0
Peer Average 30-Day Fills88.4
Peer Average Days Supply2,519
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 51.9% less volume than the regional standard for practitioners inside GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $14,964.13 across this reporting matrix range.

Provider Avg Cost Per Claim

$575.54

State Avg Cost Per Claim

$388.75

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients.

Therapeutic Applications

This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details.

Cyclosporine

Generic Formulation: CyclosporineSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 80
30-Day Fills 206.5
Days Supply 6,195
GA State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills33.7
Peer Average Days Supply997
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 281.0% higher than the standard regional baseline profile for GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $89,650.11 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,120.63

State Avg Cost Per Claim

$622.65

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection.

Therapeutic Applications

Cyclosporine eye drops are used to treat a certain type of dry eyes. They work by increasing the amount of tears you make.

Diclofenac Sodium

Generic Formulation: Diclofenac SodiumSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 24
30-Day Fills 37.7
Days Supply 1,034
GA State Average Benchmarks
Peer Average Claims51.0
Peer Average 30-Day Fills64.9
Peer Average Days Supply1,643
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 52.9% less volume than the regional standard for practitioners inside GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $389.02 across this reporting matrix range.

Provider Avg Cost Per Claim

$16.21

State Avg Cost Per Claim

$31.76

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.

Therapeutic Applications

See also Warning section. This medication is used to relieve joint pain from arthritis. Diclofenac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain.

Difluprednate

Generic Formulation: DifluprednateSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.7
Days Supply 273
GA State Average Benchmarks
Peer Average Claims36.0
Peer Average 30-Day Fills42.7
Peer Average Days Supply1,070
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 69.4% less volume than the regional standard for practitioners inside GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,748.71 across this reporting matrix range.

Provider Avg Cost Per Claim

$158.97

State Avg Cost Per Claim

$154.29

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat swelling and pain after eye surgery. It may also be used to treat a certain serious eye problem (endogenous anterior uveitis). This medication belongs to a class of drugs known as corticosteroids.

Dorzolamide Hcl

Generic Formulation: Dorzolamide HclSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 63
30-Day Fills 135.4
Days Supply 4,054
GA State Average Benchmarks
Peer Average Claims58.0
Peer Average 30-Day Fills119.4
Peer Average Days Supply3,561
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,769.98 across this reporting matrix range.

Provider Avg Cost Per Claim

$43.97

State Avg Cost Per Claim

$31.14

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors.

Dorzolamide-Timolol

Generic Formulation: Dorzolamide Hcl/Timolol MaleatSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 325
30-Day Fills 728.3
Days Supply 21,793
GA State Average Benchmarks
Peer Average Claims98.0
Peer Average 30-Day Fills207.8
Peer Average Days Supply6,213
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 231.6% higher than the standard regional baseline profile for GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $11,687.40 across this reporting matrix range.

Provider Avg Cost Per Claim

$35.96

State Avg Cost Per Claim

$32.99

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors.

Dorzolamide-Timolol

Generic Formulation: Dorzolamide/Timolol/PfSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 19
30-Day Fills 37.0
Days Supply 1,110
GA State Average Benchmarks
Peer Average Claims98.0
Peer Average 30-Day Fills207.8
Peer Average Days Supply6,213
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 80.6% less volume than the regional standard for practitioners inside GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,508.05 across this reporting matrix range.

Provider Avg Cost Per Claim

$184.63

State Avg Cost Per Claim

$32.99

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors.

Erythromycin

Generic Formulation: Erythromycin BaseSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 20
30-Day Fills 22.0
Days Supply 391
GA State Average Benchmarks
Peer Average Claims49.0
Peer Average 30-Day Fills51.3
Peer Average Days Supply810
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 59.2% less volume than the regional standard for practitioners inside GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $173.84 across this reporting matrix range.

Provider Avg Cost Per Claim

$8.69

State Avg Cost Per Claim

$26.48

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Erythromycin is used to treat a wide variety of bacterial infections. It may also be used to prevent certain bacterial infections. Erythromycin is known as a macrolide antibiotic. It works by stopping the growth of bacteria. This antibiotic treats or prevents only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Fluorometholone

Generic Formulation: FluorometholoneSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 21
30-Day Fills 30.4
Days Supply 818
GA State Average Benchmarks
Peer Average Claims34.0
Peer Average 30-Day Fills49.9
Peer Average Days Supply1,312
Conservative Utilization

This provider writes prescriptions for this formulation 38.2% less frequently than the standard regional baseline metric for practitioners inside GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,053.30 across this reporting matrix range.

Provider Avg Cost Per Claim

$97.78

State Avg Cost Per Claim

$88.99

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A glucocorticoid employed, usually as eye drops, in the treatment of allergic and inflammatory conditions of the eye. It has also been used topically in the treatment of various skin disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p732)

Therapeutic Applications

This medication is used to treat certain eye conditions due to inflammation or injury. Fluorometholone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids.

Gabapentin

Generic Formulation: GabapentinSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 12
30-Day Fills 16.0
Days Supply 464
GA State Average Benchmarks
Peer Average Claims115.0
Peer Average 30-Day Fills179.7
Peer Average Days Supply5,028
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 89.6% less volume than the regional standard for practitioners inside GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $164.47 across this reporting matrix range.

Provider Avg Cost Per Claim

$13.71

State Avg Cost Per Claim

$19.38

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Ketorolac Tromethamine

Generic Formulation: Ketorolac TromethamineSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 67
30-Day Fills 67.0
Days Supply 1,650
GA State Average Benchmarks
Peer Average Claims53.0
Peer Average 30-Day Fills58.6
Peer Average Days Supply1,261
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 26.4% more claims than the standard regional baseline profile for GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,556.39 across this reporting matrix range.

Provider Avg Cost Per Claim

$23.23

State Avg Cost Per Claim

$25.25

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is a non-steroidal anti-inflammatory agent used for analgesia for postoperative pain and inhibits cyclooxygenase activity.

Therapeutic Applications

This medication is used to temporarily relieve itching eyes caused by seasonal allergies. It is also used to prevent and treat eye swelling due to a certain type of eye surgery (cataract removal). Ketorolac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking certain natural substances in your body to reduce pain and swelling.

Latanoprost

Generic Formulation: LatanoprostSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 455
30-Day Fills 1,098.1
Days Supply 32,606
GA State Average Benchmarks
Peer Average Claims174.0
Peer Average 30-Day Fills322.9
Peer Average Days Supply9,270
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 161.5% higher than the standard regional baseline profile for GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $13,249.37 across this reporting matrix range.

Provider Avg Cost Per Claim

$29.12

State Avg Cost Per Claim

$21.70

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA.

Therapeutic Applications

Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.

Loteprednol Etabonate

Generic Formulation: Loteprednol EtabonateSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 21
30-Day Fills 23.0
Days Supply 620
GA State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills26.5
Peer Average Days Supply675
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,193.21 across this reporting matrix range.

Provider Avg Cost Per Claim

$152.06

State Avg Cost Per Claim

$198.40

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An androstadiene derivative corticosteroid that is used as an ANTI-ALLERGIC AGENT for the treatment of inflammatory and allergic eye conditions.

Therapeutic Applications

This medication is used to temporarily relieve seasonal allergy symptoms of the eyes such as swelling, redness, and itching. Loteprednol belongs to a class of drugs known as corticosteroids.

Lumigan

Generic Formulation: BimatoprostSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 49
30-Day Fills 95.8
Days Supply 2,768
GA State Average Benchmarks
Peer Average Claims86.0
Peer Average 30-Day Fills151.6
Peer Average Days Supply4,360
Conservative Utilization

This provider writes prescriptions for this formulation 43.0% less frequently than the standard regional baseline metric for practitioners inside GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $27,743.04 across this reporting matrix range.

Provider Avg Cost Per Claim

$566.18

State Avg Cost Per Claim

$475.10

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

Therapeutic Applications

Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure.

Moxifloxacin

Generic Formulation: Moxifloxacin HclSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 16
30-Day Fills 16.0
Days Supply 259
GA State Average Benchmarks
Peer Average Claims94.0
Peer Average 30-Day Fills95.5
Peer Average Days Supply1,533
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 83.0% less volume than the regional standard for practitioners inside GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $413.02 across this reporting matrix range.

Provider Avg Cost Per Claim

$25.81

State Avg Cost Per Claim

$34.19

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A fluoroquinolone that acts as an inhibitor of DNA TOPOISOMERASE II and is used as a broad-spectrum antibacterial agent.

Therapeutic Applications

This medication is a quinolone antibiotic used for eye infections.

Neomycin-Polymyxin-Dexameth

Generic Formulation: Neomycin/Polymyxin B/DexamethaSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 44
30-Day Fills 44.0
Days Supply 656
GA State Average Benchmarks
Peer Average Claims41.0
Peer Average 30-Day Fills42.7
Peer Average Days Supply669
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $647.18 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.71

State Avg Cost Per Claim

$14.07

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat conditions involving swelling (inflammation) of the eyes and to treat or prevent bacterial eye infections. This product contains neomycin and polymyxin, antibiotics that work by stopping the growth of bacteria. It also contains dexamethasone, an anti-inflammatory corticosteroid that works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections and may worsen them (such as infections caused by viruses, fungi, mycobacteria). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.

Prednisolone Acetate

Generic Formulation: Prednisolone AcetateSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 71
30-Day Fills 110.1
Days Supply 3,031
GA State Average Benchmarks
Peer Average Claims114.0
Peer Average 30-Day Fills145.7
Peer Average Days Supply3,747
Conservative Utilization

This provider writes prescriptions for this formulation 37.7% less frequently than the standard regional baseline metric for practitioners inside GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,985.37 across this reporting matrix range.

Provider Avg Cost Per Claim

$42.05

State Avg Cost Per Claim

$50.23

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat certain eye conditions due to inflammation or injury. Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids.

Restasis

Generic Formulation: CyclosporineSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 126
30-Day Fills 273.8
Days Supply 8,214
GA State Average Benchmarks
Peer Average Claims51.0
Peer Average 30-Day Fills89.0
Peer Average Days Supply2,631
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 147.1% higher than the standard regional baseline profile for GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $187,622.66 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,489.07

State Avg Cost Per Claim

$1,155.03

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection.

Therapeutic Applications

Cyclosporine eye drops are used to treat a certain type of dry eyes. They work by increasing the amount of tears you make.

Rhopressa

Generic Formulation: Netarsudil MesylateSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 22
30-Day Fills 44.0
Days Supply 1,266
GA State Average Benchmarks
Peer Average Claims56.0
Peer Average 30-Day Fills86.1
Peer Average Days Supply2,401
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 60.7% less volume than the regional standard for practitioners inside GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $16,888.53 across this reporting matrix range.

Provider Avg Cost Per Claim

$767.66

State Avg Cost Per Claim

$480.53

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Netarsudil is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). This medication is thought to work by increasing the flow of fluid out of the eye. This helps lower pressure inside the eye. Lowering high pressure inside the eye can help prevent loss of vision or blindness.

Rocklatan

Generic Formulation: Netarsudil Mesylat/LatanoprostSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 28
30-Day Fills 45.3
Days Supply 1,282
GA State Average Benchmarks
Peer Average Claims43.0
Peer Average 30-Day Fills65.7
Peer Average Days Supply1,828
Conservative Utilization

This provider writes prescriptions for this formulation 34.9% less frequently than the standard regional baseline metric for practitioners inside GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $14,938.70 across this reporting matrix range.

Provider Avg Cost Per Claim

$533.53

State Avg Cost Per Claim

$525.01

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Netarsudil/latanoprost is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Lowering high pressure inside the eye can help prevent vision loss or blindness.

Simbrinza

Generic Formulation: Brinzolamide/Brimonidine TartSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 19
30-Day Fills 39.5
Days Supply 1,183
GA State Average Benchmarks
Peer Average Claims32.0
Peer Average 30-Day Fills49.1
Peer Average Days Supply1,431
Conservative Utilization

This provider writes prescriptions for this formulation 40.6% less frequently than the standard regional baseline metric for practitioners inside GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $8,016.99 across this reporting matrix range.

Provider Avg Cost Per Claim

$421.95

State Avg Cost Per Claim

$273.72

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This product contains two medications used to treat high pressure in the eye due to glaucoma (open-angle glaucoma-type) or a certain other eye disease (ocular hypertension). Lowering high pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This product contains brinzolamide and brimonidine. These two medications work together to decrease the amount of fluid within the eye. Brinzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. Brimonidine belongs to a class of drugs known as alpha agonists. This product is not recommended for use in children younger than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details.

Tafluprost

Generic Formulation: Tafluprost/PfSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 14
30-Day Fills 30.0
Days Supply 900
GA State Average Benchmarks
Peer Average Claims--
Peer Average 30-Day Fills--
Peer Average Days Supply--

Provider Avg Cost Per Claim

$343.92

State Avg Cost Per Claim

--

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Tafluprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure.

Timolol Maleate

Generic Formulation: Timolol MaleateSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 244
30-Day Fills 572.2
Days Supply 17,035
GA State Average Benchmarks
Peer Average Claims86.0
Peer Average 30-Day Fills182.2
Peer Average Days Supply5,377
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 183.7% higher than the standard regional baseline profile for GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,762.53 across this reporting matrix range.

Provider Avg Cost Per Claim

$15.42

State Avg Cost Per Claim

$21.05

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor.

Therapeutic Applications

This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers.

Travoprost

Generic Formulation: TravoprostSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 34
30-Day Fills 64.0
Days Supply 1,915
GA State Average Benchmarks
Peer Average Claims39.0
Peer Average 30-Day Fills67.9
Peer Average Days Supply1,947
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $8,948.91 across this reporting matrix range.

Provider Avg Cost Per Claim

$263.20

State Avg Cost Per Claim

$236.34

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

Therapeutic Applications

Travoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure.

Tyrvaya

Generic Formulation: Varenicline TartrateSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 28
30-Day Fills 31.0
Days Supply 930
GA State Average Benchmarks
Peer Average Claims17.0
Peer Average 30-Day Fills19.3
Peer Average Days Supply577
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 64.7% higher than the standard regional baseline profile for GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $19,703.05 across this reporting matrix range.

Provider Avg Cost Per Claim

$703.68

State Avg Cost Per Claim

$693.28

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzazepine derivative that functions as an ALPHA4-BETA2 NICOTINIC RECEPTOR partial agonist. It is used for SMOKING CESSATION.

Therapeutic Applications

Varenicline is used by adults to help stop smoking. To increase your chance of success, use this medication with a stop-smoking program that includes education, support, and counseling. Quitting smoking lowers your risk of heart and lung disease, as well as cancer. Varenicline works by blocking nicotine's effects in the brain that make you want to smoke. Discuss the risks and benefits of this medication, as well as other ways to quit smoking (such as nicotine replacement treatment), with your doctor.

Valacyclovir

Generic Formulation: Valacyclovir HclSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 45
30-Day Fills 74.0
Days Supply 2,059
GA State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills33.4
Peer Average Days Supply763
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 95.7% higher than the standard regional baseline profile for GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,589.27 across this reporting matrix range.

Provider Avg Cost Per Claim

$57.54

State Avg Cost Per Claim

$50.62

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A prodrug of acyclovir that is used in the treatment of HERPES ZOSTER and HERPES SIMPLEX VIRUS INFECTION of the skin and mucous membranes, including GENITAL HERPES.

Therapeutic Applications

Valacyclovir is used to treat infections caused by certain types of viruses. In children, it is used to treat cold sores around the mouth (caused by herpes simplex) and chickenpox (caused by varicella zoster). In adults, it is used to treat shingles (caused by herpes zoster) and cold sores around the mouth. Valacyclovir is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, this medication is used to reduce the number of future episodes. Valacyclovir is an antiviral drug. It stops the growth of certain viruses. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Valacyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal.

Vyzulta

Generic Formulation: Latanoprostene BunodSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 14
30-Day Fills 25.7
Days Supply 660
GA State Average Benchmarks
Peer Average Claims36.0
Peer Average 30-Day Fills55.6
Peer Average Days Supply1,578
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 61.1% less volume than the regional standard for practitioners inside GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $7,409.00 across this reporting matrix range.

Provider Avg Cost Per Claim

$529.21

State Avg Cost Per Claim

$446.86

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Latanoprostene bunod is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye can help prevent blindness. This medication works by controlling the flow of fluid within the eye to maintain a normal pressure.

Xiidra

Generic Formulation: LifitegrastSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 16
30-Day Fills 44.0
Days Supply 1,320
GA State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills43.9
Peer Average Days Supply1,317
Conservative Utilization

This provider writes prescriptions for this formulation 40.7% less frequently than the standard regional baseline metric for practitioners inside GA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $32,689.66 across this reporting matrix range.

Provider Avg Cost Per Claim

$2,043.10

State Avg Cost Per Claim

$1,078.00

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat dry eye disease.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. BONNIE J BROOKS M.D. provides transparency into local medical care patterns within Brunswick, GA.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Ophthalmology** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.